Table 3.
AA w t(11;14) (N = 117) |
AA w/o t(11;14) (N = 968) |
Whites w t(11;14) (N = 266) |
Whites w/o t(11;14) (N = 2,187) |
||||||
---|---|---|---|---|---|---|---|---|---|
Outcomes | N | Prob (95% CI) |
N | Prob (95% CI) |
N | Prob (95% CI) |
N | Prob (95% CI) |
p-value |
TRM | 115 | 959 | 259 | 2164 | 0.68 | ||||
100-day | 1 (0–3)% | 1 (0–1)% | 1 (0–3)% | 1 (0–1)% | 0.77 | ||||
1-year | 2 (0–5)% | 1 (1–2)% | 3 (1–5)% | 2 (1–2)% | 0.66 | ||||
2-year | 2 (0–5)% | 2 (1–3)% | 3 (1–6)% | 2 (2–3)% | 0.79 | ||||
PFS | 115 | 959 | 259 | 2164 | 0.06 | ||||
1-year | 84 (76–90)% | 81 (78–83)% | 76 (70–81)% | 79 (78–81)% | 0.20 | ||||
2-year | 65 (54–74)% | 65 (61–68)% | 54 (47–60)% | 61 (59–63)% | 0.02 | ||||
OS | 117 | 968 | 266 | 2187 | 0.41 | ||||
1-year | 95 (90–98)% | 95 (94–97)% | 93 (90–96)% | 95 (94–96)% | 0.69 | ||||
2-year | 91 (85–96)% | 89 (86–91)% | 86 (81–90)% | 87 (86–89)% | 0.35 |
AA; Africans Americans, N; number, Prob; probability, w; with, w/o without, TRM; transplant related mortality, PFS; progression free survival, OS; overall survival, N; number evaluated